Prospective observational study to evaluate the quality of life of patients with hemophilia a without inhibitors (HEMOLIFE)
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ROCHE FARMA, SA
- Execution start: 06/07/2020
- End of execution: 30/11/2021
- IP: